Pathologic classification of lupus glomerulonephritis The primary clinical purposes for pathologic classification system are to: Facilitate communication:

Slides:



Advertisements
Similar presentations
Materials and Methods Cont.
Advertisements

WHO Classification of Lupus Nephritis
ANCA disease: pathology Dušan Ferluga Institute of Pathology, Faculty of Medicine, University of Ljubljana Ljubljana, Slovenia.
Renal Pathology Review
CME on Renal Pathology, 17th December 08, Pune Indian Society of Renal and Transplantation Pathology in collaboration with Indian Society of Nephrology.
Małgorzata Wągrowska-Danilewicz1, Marian Danilewicz2
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Role of recurrent disease for late allograft loss Fernando G. Cosio Mayo Clinic, Rochester MN 10 th Banff conference on allograft pathology.
Glomerular Diseases Dr. Atapour Differential diagnosis and evaluation of glomerular disease.
Proteinuria Outcome Lupus Nephritis Classes of Lupus Nephritis I.Minimal II.Mesangial III.Focal proliferative* IV.Diffuse proliferative* V.Membranous**
The nephrotic syndrome Def: It is a clinico -biochemical state of many causes Features 1-Heavy proteinuria. 2-Hypoproteinemia.( decrease protein in the.
Nephritic Syndromes Dr. Raid Jastania.
Nephrotic Syndrome Dr. Raid Jastania. Causes Minimal Change disease (lipoid nephrosis) Membranous glomerulonephritis Focal segmental glomerulosclerosis.
Lupus Nephritis in Children Renal involvement in SLE: 30% - 70% Renal involvement in SLE: 30% - 70% Most diagnosis in adolescence, rare < 5y/o Most diagnosis.
Lupus Nephritis Emily Chang April 13, The “Glom”
Lupus glomerulonephritis. summary Etiology and pathogenesis Morphologic classification and clinical relevance Class switching in follow-up biopsies Alternative.
Zehra Eren M.D. Nephrology Department. The Kidney in:  Congestive heart failure  Liver disease  Diabetes Mellitus  Systemic Vasculitis  İnfections.
ROLE OF RENAL BIOPSY IN SILENT LUPUS NEPHRITIS M.E. Guerra 1, Y. Arce 2, M.M Díaz 3, P. Moya 4. J. Ballarín 3, F. Algaba 5 1 Department of Pathology. Central.
OBJECTIVES NOT TO BE A NEPHROLOGIST
ISRTPCON and CME AIIMS NEW DELHI Sept,2013 Dr Kiran K Senior Resident, PDCC-Renal and Transplant Pathology Department of Histopathology PGIMER, Chandigarh.
Histological classification of diabetic nephropathy
Acute Glomerular Nephritis
Urinary System Tutorial Glomerulonephritis
Renal Ultrastructure Atlas
Glomerulonephritis Dr. Abdelaty Shawky Dr. Gehan mohamed.
Interstitial nephritis associated with PostInfectious GN PRAET MARLEEN, MD, PhD UNIVERSITY HOSPITAL GHENT.
Clinical Approach to a Child with Hematuria Careful history, physical examination, urinary dipstick & urinalysis.
WHO Classification of Lupus Nephritis
WHO Classification of Lupus Nephritis
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
And Review of Acute nephritis Syndromes. Karyomegalic Tubulointerstitial Nephritis  Symptoms: Recurrent Pneumonias Renal failure leading invariably to.
Kidney Lecture 2 Non-immune Glomerular Disease, Systemic Diseases, Infections, Vascular Diseases.
KIDNEY LECTURES DayTimeQuarter 5LecturerSubject Tue 10:00 a-11:00 a12/1/2015Lu, YuxinKidney I - Glomerular Disease Tue 11:00 a-12:00 p12/1/2015Lu,

Glomerulonephritis By Dr. Abdelaty Shawky Associate professor of pathology.
Lecture:20 [Path] Glomerular Pathology [Part 1] Objectives The objective of the lecture is to discuss the pathogenesis and criteria for diagnosis of glomerular.
Causes of membranous nephropathy 신장내과 R 3 김경엽. Membranous nephropathy and focal glomerulosclerosis –Most common causes of the nephrotic syndrome in nondiabetic.
Systemic lupus erythematosus
Figure 1 Schematic representation of idiopathic nephrotic syndrome,
“Systemic Lupus Erythematosus” Renal features
Overzicht van relevante classificatiesystemen in de nefropathologie
Renal disease in SLE R4 이설라/Prof.임천규.
The nephrotic syndrome
Important notes: Dear students…
Glomerular pathology in systemic disease
Mark A. Lusco, MD, Agnes B. Fogo, MD, Behzad Najafian, MD, Charles E
ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series Collister et al. Am J Nephrol.
Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, Charles E
Figure 1 Pathological features of lupus nephritis subtypes
Volume 65, Issue 2, Pages (February 2004)
A 61-Year-Old Man With Membranoproliferative Glomerulonephritis
Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification 
Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, Charles E
AJKD Atlas of Renal Pathology: Minimal Mesangial and Mesangial Proliferative Lupus Nephritis (ISN/RPS Class I and II)  Agnes B. Fogo, MD, Mark A. Lusco,
Volume 76, Issue 5, Pages (September 2009)
Membranoproliferative Glomerulonephritis
Volume 57, Issue 3, Pages (March 2000)
World Kidney Day 2016: Kidney Disease & Children
Lupus Nephritis: Mesangial and Membranous Forms (WHO II and V)
Lupus Nephritis: Proliferative Forms (WHO III, IV)
HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases1  Mark Haas, Sadhana Kaul, Joseph A.
Volume 59, Issue 6, Pages (June 2001)
AJKD Atlas of Renal Pathology: Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits  Mark A. Lusco, MD, Agnes B. Fogo, MD, Behzad.
Volume 88, Issue 4, Pages (October 2015)
Volume 65, Issue 2, Pages (February 2004)
AJKD Atlas of Renal Pathology: Anti–Glomerular Basement Membrane Antibody– Mediated Glomerulonephritis  Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian,
Post-transplant membranous glomerulonephritis as a manifestation of chronic antibody-mediated rejection Hyeon Joo Jeong, Beom Jin Lim, Myoung Soo Kima,
C1q Nephropathy American Journal of Kidney Diseases
Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, Charles E
Unmasking a unique glomerular lesion
Presentation transcript:

Pathologic classification of lupus glomerulonephritis The primary clinical purposes for pathologic classification system are to: Facilitate communication: Between pathologists Between pathologists and clilinicalans Between clinicians In understanding the literature Facilitate clinical management: Guiding treatment Suggesting prognosis Indicating an etiology or pathogenic mechanism

Baldwin’s morphologic classification of lupus nephritis  Mesangial lupus nephritis  Focal proliferative lupus nephritis  Diffuse proliferative lupus nephritis  Membranous lupus nephritis *Mesangial lupus nephritis was add in a 1977 publication (Am J Med 62:12-30, 1977) to the other three categories that were published in 1970 (Ann Intern Med 73:929, 1970)

Who classified lupus nephritis? “Original WHO Classification” Buffalo, NY, 1974; or Geneva, 1975 “Modified WHO Classification ” ISKDC, Paris, 1980 (Churg and Sobin, 1982) “Modified WHO Classification ” Jacob churg 1995

Sinniah and Feng, Clin, Nephrol. 6:340-51, 1976 (“preliminary histologic categories put forward by the WHO committee on Morphologic classification and Nomenclature or Renal diseases, Geneva, June, 1975 ”)  Minimal (“nil”) lesion (normal by light microscopy)  Minimal lesion with mesangial hypercellularity  Focal and segmental glomerulonephritis  Membranous glomerulonephritis  Diffuse proliferative glomerulonephritis  Diffuse membranoproliferative glomerulonephritis

Appel, Silva, Pirani, et al, Medicine 57: ,1978 (“according to a classification proposed by the WHO ”)  Class I. normal normal by LM, IM and IF  Class II. Messangial changes A.minimal alterations (normal by LM, mesangial deposits by IF and EM) B. mesangial glomerulitis (mesangial hypercellularity)  Class III. Focal and segmental proliferative glomerulonephritis (<50% glomeruli involved)  Class IV. Diffuse proliferative glomerulonephritis (<50% glomeruli involved)  Class V. membranous glomerulonephritis Pure Mixed patterns (such as Class III associated with Class V)

Jacob churg, 1982 (based on modifications at the ISKDC): “WHO morphologic classification of Lupus Nephritis”  I. normal a. Nil (by all techniques) b. normal by LM but deposits by EM or IF  II. Pure mesangial alterations (mesangiopathy) a. mesangial widening mild hypercellularty b. moderate hypercellularity  III. Focal segmental glomerulonephritis a. active necrotizing lesions b. active and sclerosing lesions c. sclerosing lesions  IV. Diffuse glomerulonephritis a. without segmental lesions b.c. and d. like a.b and c. above  V. diffuse membranous glomerulonephritis a. pure b. associated with category II c. associated with actegory III d. associated with category IV  VI. Advanced sclerosing glomerulonephritis

Jacob Churg 1995: WHO morphologic classification of Lupus nephritis (modified)  I. Normal a. nil( by all techniques) b. normal by LM but deposits by EM or IF  II Pure Mesangial Alteration (Mesangiopathy) a. mesanglal widening mild hypercellularity b. moderate hypercellularity  III Focal Segmental Glomerulonephritis a. active necrotizing lesion b. active and sclerosing lesions c. sclerosing lesions  IV. Diffuse Glomerulonephritis a. without segment lesions b. c. and d, like A, B, and C above  V. Diffuse Membranous Glomerulonephritis a. pure b. associted with category II  VI. Advanced Sclerosing Glomerulonephritis

Controversies in WHO classification (WHO I and II ) Majority approach  Class I: no lesion by LM, EM, IM  Class IIA. no lesion by LM, but mesangial deposits by IM and/or EM  IIB. mesangial hypercellularty Minority approach  IA. No lesion by LM, EM or IM  IB. no lesion by LM but mesangial deposits by EM and/or IM  IIA. mild mesangial hypercellularty  IIB. moderate mesangial hypercellularity

Controversies in WHO classication (WHO III and IV) Majority apporach Class III :focal GN affecting <50% of glomeruli Class IV: diffuse GN affeceting > 50% of glomeruli Class V: membranous GN A. no hypercellularity B. plus class II Mixed class III or IV plus V Minority approach Segmental GN affecting 50% of glomeruli Diffuse non-seegmental GN Affecting <50 % of glomeruli Membranous GN  A. no hypercellularity  B. plus class II  C. plus class III  D. plus class IV

Anyone WHO isn’t confused really doesn’t understand the situsion. Edward R. Murrow

Proposal of the international society of nephrology and renal pathological society working group on the classification of lupus glomerulonephritis “The major objective is to standardize definitions, emphasize clinically relevant lesions, and encourage uniform and reproducible reporting between centers.”

2002 ISN/RPS Consensus Conference on the Classification of Lupus Nephritis (preliminary)  Class I. Minimal mesangial lupus glomerulonephritis (LGN)  Class II. Mesangial proliferative LGN  Class III. Focal LGN ( involving < 50 % of glomeruli)  Class IV.Diffuse LGN ( involving 50% or > glomeruli)  Class V. Membranous LGN  Class VI.Advanced sclerotic LGN ( >90 % sclerotic glomeruli ) *for classes III and IV, the diagnosis should include one of the following: with active lesions/with active and chronic lesions/Inactive with scars *for classes III and IV, the diagnosis should include the percentage of glomeruli with fibrinoid necrosis and/or cellular crescents when present *for class IV, the diagnosis should include one of the following: predominantly segmental (IV-S)/predominantly global (IV-G) *class V may occur in combination with III or IV in which case both will be diagnosed

2002 ISN/RPS Consensus Conference on the Classification of Lupus Nephritis (preliminary) Class I. Minimal mesangial lupus glomerulonephritis Normal glomeruli by LM but mnesangeial immune deposits by IF and/ or EM.

2002 ISN/RPS Consensus Conference on the Classification of Lupus Nephritis (preliminary) Class II. Mesangial proliferative LGN Purely mesangial hyhpercellularity of any degree or mesangial matrex expansion by LM with immune deposits, predominatly mesangial with none or few, isolated subepithelial and/or subendothelial deposits by IF and/or EM not visible by LM.

2002 ISN/RPS Consensus Conference on the Classification of Lupus Nephritis (preliminary) Class II. Mesangial proliferative lupus glomerulonephritis Purely mesangial hyhpercellularity of any degree or mesangial matrex expansion by LM with immune deposits, predominatly mesangial with none or few, isolated subepithelial and/or subendothelial deposits by IF and/or EM not visible by LM.

2002 ISN/RPS Consensus Conference on the Classification of Lupus Nephritis (preliminary) Class III. Focal lupus glomerulonephritis Active or inactive focal, segmental and /or global endo- and /or extracapiliary GN, typically with focal, subendothelial immune extracapillary GN, with or without focal or diffuse mesangial alterations. III (A)Active focal proliferative LGN III (A/C)Active and sclerotic focal proliferative LGN III (C)Inactive sclerotic focal LGN *Indicate the proportion of glomeruli with active and with sclerotic lesions *Indicate the proportion of glomeruli with fibrinoid necrosis and/or cellular crescents

2002 ISN/RPS Consensus Conference on the Classification of Lupus Nephritis (preliminary) Class IV. Diffuse segmental (IV-S) or global (IV-G) LGN Active or inactive diffuse (50% or more involved glomeruli), segmental or global endo- or extracapiliary GN with diffuse subendothelial immune deposits, with or without mesangial alterations. This class is divided into diffuse segmental (IV-S) when >50% of the involved glomeruli have segmental lesions, and diffuse global (IV-G) when >50% of the involved glomeruli have ealobal lesions. IV (A) Active diffuse segmental or global proliferative LGN IV (A/C) Diffuse segmental or global proliferative & sclerotic LGN IV (C) Diffuse segmental or global sclerotic LGN *Indicate the proportion of glomeruli with active and with sclerotic lesions *Indicate the proportion of glomeruli with fibrinoid necrosis and/or cresents

2002 ISN/RPS Consensus Conference on the Classification of Lupus Nephritis (preliminary) Class V. membranous LGN Numerous global or segmental subepithelial immune deposits or their morphologic sequelae by LM and/or IF and/or EM with or without mesangial alterations. May occur in combination with III or IV in which case both will be diagnosed

2002 ISN/RPS Consensus Conference on the Classification of Lupus Nephritis (preliminary) Class VI. Advanced sclerotic lupus glomerulonephritis 90 % or > glomeruli globally sclerosed without residual activity

2002 ISN/RPS Consensus Conference on the Classification of Lupus Nephritis (preliminary)  Class IMinimal mesangial lupus glomerulonephritis (LGN)  Class IIMesangial proliferative LGN  Class IIIFocal LGN (Involving < 50% of glomeruli)  Class IV Diffuse LGN (Involving >= 50% gloeruli, IV-S and IV-G)  Class VMembranous LGN  Class VIAdvanced sclerotic LGN (> 90% sclerotic glomeruli)

References 1. Slnnlah R, Feng PH: Lupus nephritis: correlation between light, electron microscopic and immunofluorescent findings and renal function. Clinical Nephrol 6: , Appel GB, Silva FG, Pirani CL: Renal Involvement In systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine 75: , Churg J, Sobin LH: Renal disease: Classification and atlas of glomerular disease. Tokyo, Igaku-Shoin, Churg J, Bernstein J, Glassock RJ: Renal disease: classification and atlas of glomerular diseases, second edition. New York, Tokyo, Igaky-Shoin, Weening JJ, D’Agati VD, Schwartz M, Seshan SV, et al.: Classification of gloerulonephritis in systemic lupus erythematosus, in preparation, 2003